Artificial Organs

Artificial Organs in Developing Countries
pp. 173-173(1)
Author: Leirner A.A.

Development of Artificial Organs to Treat Chronic Renal Failure in Latin America
pp. 174-176(3)
Authors: Treviño-Becerra A.

The Influence of Recombinant Human Erythropoietin on Tumor Necrosis Factor and Interleukin-10 Production by Whole Blood Cell Cultures in Hemodialysis Patients
pp. 177-181(5)
Authors: Bryl E.; Mys´liwska J.; Dbska-S´lizien´ A.; Rachon´ D.; Buo B.; Lizakowski S.; Mys´liwski A.; Rutkowski B.

The Management of End-Stage Renal Disease in India
pp. 182-186(5)
Author: Mani M.K.

Treatment of End-Stage Renal Disease in Central and Eastern Europe: Overview of Current Status and Future Needs
pp. 187-191(5)
Authors: Rutkowski B.; Ciocalteu A.; Djukanovic L.; Kiss I.; Kovac A.; Polenakovic M.; Puretic Z.; Rozental R.; Stanaityte M.; Tareyeva I.; Teplan V.; Zavitz J.; Stefan K.; Rado K.

The Acute Effect of Intravenously Administered Recombinant Human Erythropoietin on the Immune Response of Uremic Patients Maintained on Regular Hemodialysis
pp. 192-196(5)
Authors: William J.; Saad N.; Salib M.; Riad H.; Mahran K.S.; Iskander I.; Cozma G.; Barsoum R.

Plasmapheresis in the Treatment of Posttransplant Cardiomyopathy
pp. 197-202(6)
Authors: Dzemeshkevich S.; Ragimov A.; Mikhaylov Y.; Roitman E.; Adrianov S.; Ryikunov I.; Abugov S.; Sheremetyeva G.; Alekseeva L.; Vinnitsky L.

Anionic Collagen: Polymer Composites with Improved Dielectric and Rheological Properties
pp. 203-209(7)
Authors: Goissis G.; Piccirili L.; Goes J.C.; de Guzzi Plepis A.M.; Das-Gupta D.K.

The Chemical Protecting Group Concept Applied in Crosslinking of Natural Tissues with Glutaraldehyde Acetals
pp. 210-214(5)
Authors: Goissis G.; Yoshioka S.A.; Braile D.M.; Ramirez V.D.A.

The Controlled Release of Antibiotic by Hydroxyapatite: Anionic Collagen Composites
pp. 215-221(7)
Authors: Martins V.C.A.; Goissis G.; Ribeiro A.C.; Marcantônio Jr E.; Bet M.R.

Migration Resistant, Blood-Compatible Plasticized Polyvinyl Chloride for [Medical and Related Applications
pp. 222-229(8)
Authors: Lakshmi S.; Jayakrishnan A.

Assisted Circulation for End-Stage Chronic Heart Failure
pp. 230-236(7)
Author: Liotta D.

Availability and Limits of Intermediate Cardiovascular Technology
pp. 237-242(6)
Author: Puruhito

BeStent—The Serpentine Balloon Expandable Stent: Review ofMechanical Properties and Clinical Experience
pp. 243-249(7)
Authors: Roguin A.; Beyar R.

Implantable Control, Telemetry, and Solar Energy System in the MovingActuator Type Total Artificial Heart
pp. 250-259(10)
Authors: Ahn J.M.; Lee J.H.; Choi S.W.; Kim W.E.; Omn K.S.; Park S.K.; Kim W.G.; Roh J.R.; Min B.G.

Electromechanical Unit Helps Artificial Heart
pp. 260-262(3)
Authors: Morozov V.V.; Zhdanov A.V.

Ethics of the Allocation of Highly Advanced Medical Technologies
pp. 263-268(6)
Author: Sass H-M.

Enosseal Cylindric Implants: Experience from 2nd Dental Clinic, Brno,Czech Republic
pp. 269-269(1)
Authors: Vanek J.; Bartáková S.; Prachár P.; Dostál M.

Upcoming Meetings
pp. 269-270(2)